Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in ASND — Ascendis Pharma A/S

CIK 1595888 NEW YORK, NY
Back to ASND Full portfolio

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$49,914,247
+$49,914,247 QoQ
Shares Held
187,141
Ownership
0.285%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#45
of 308 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ASND Over Time

Shares Held

Position Value (USD)

Derivatives in ASND

reported options exposure · as of Jun 30, 2026
CallValue
$18,643,728
CallShares
69,900
PutValue
$7,014,736
PutShares
26,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. ASND ranks #9 (3.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in ASND

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,014,736 26,300
2026-06-30 $49,914,247 187,141
2026-06-30 $18,643,728 69,900
2026-03-31 $15,187,672 66,400
2026-03-31 $2,287,300 10,000
2025-12-31 $1,961,808 9,200
2025-12-31 $15,694,464 73,600
2025-12-31 $4,526,018 21,225
2025-09-30 $2,763,459 13,900
2025-09-30 $14,632,416 73,600
2025-06-30 $655,880 3,800
2025-06-30 $4,901,840 28,400
2025-03-31 $11,502,468 73,800
2025-03-31 $3,522,436 22,600
2025-03-31 $7,527,880 48,299
2024-12-31 $357,942 2,600
2024-12-31 $15,336,438 111,400
2024-12-31 $4,863,880 35,330
2024-09-30 $1,911,168 12,800
2024-09-30 $11,601,387 77,700
2024-09-30 $5,293,636 35,454
2024-06-30 $2,217,674 16,261
2024-03-31 $3,082,960 20,394
2023-12-31 $3,963,393 31,468
2023-09-30 $2,314,499 24,717
2023-06-30 $6,641,538 74,415
2023-03-31 $1,536,784 14,333
2022-12-31 $6,459,821 52,893
2022-09-30 $7,360,888 71,285
2022-06-30 $3,769,899 40,554
2022-03-31 $4,846,968 41,300
2022-03-31 $10,034,280 85,500
2022-03-31 $3,342,647 28,482
2021-12-31 $834,086 6,200
2021-12-31 $1,966,962 14,621
2021-12-31 $2,260,104 16,800
2021-09-30 $4,957,029 31,100
2021-09-30 $1,065,521 6,685
2021-09-30 $3,044,349 19,100
2021-06-30 $802,455 6,100
2021-06-30 $960,315 7,300
2021-03-31 $786,168 6,100
2021-03-31 $283,536 2,200
2021-03-31 $544,002 4,221
2020-12-31 $3,519,058 21,100
2020-12-31 $3,502,380 21,000
2020-12-31 $659,448 3,954
2020-09-30 $5,821,412 37,723
2020-09-30 $1,095,672 7,100
2020-06-30 $6,003,704 40,593

Report a Problem

Category
Description
Email (optional, for follow-up)